Back to catalogue
BiologicalHepatitis, Antiviral & Vaccines
HeberNasvac®
Therapeutic nasal vaccine for chronic hepatitis B under investigation.
Product information
Therapeutic nasal vaccine (HeberNasvac) for chronic hepatitis B. Developed by CIGB. Phase III trials.
Indications
Chronic hepatitis B (investigational therapeutic vaccine).
Formulation
Nasal therapeutic vaccine containing HBV antigens.
Administration
Intranasal, per clinical protocol.
Precautions
Investigational product — available only through authorized clinical programs.
Product information
- Manufacturer
- CIGB, Havana
- Regulatory status
- Investigational — Phase III trials
